Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Hervás Morón, A."'
Autor:
Almudena Zapatero, Xavier Maldonado Pijoan, Antonio Gómez-Caamaño, José Pardo Masferrer, Víctor Macías Hernández, Asunción Hervás Morón, Julia Luisa Muñoz García, Amalia Palacios Eito, Paloma Anguita-Alonso, Cristina González-Junco, José López Torrecilla
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background Health-related quality of life (HRQoL) is greatly affected by prostate cancer (PCa) and associated treatments. This study aimed to measure the impact of radiotherapy on HRQoL and to further validate the Spanish version of the 16-i
Externí odkaz:
https://doaj.org/article/0f12d27526954c34b557d8ce235d1d99
Autor:
Pedro C. Lara, Juan I. Rodríguez-Melcón, Amalia Palacios-Eito, Antonio Lozano, Asunción Hervás-Morón, Elena Villafranca, Alfonso Gómez-Iturriaga, Gemma Sancho, Xavier Maldonado
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundIntermediate-risk prostate cancer (PCa) is usually treated by a combination of external beam radiation therapy (EBRT) and a short course of androgen deprivation therapy (ADT). ADT is associated with multiple side effects, including weight g
Externí odkaz:
https://doaj.org/article/c70f8a99ebe74f68bb2aca7108584a78
Autor:
Cadeddu, Giovanna ⁎, Hervás-Morón, Asunción, Martín-Martín, Margarita, Pelari-Mici, Lira, Ytuza-Charahua de Kirsch, Kathy, Hernández-Corrales, Antonio, Vallejo-Ocaña, Carmen, Sastre-Gallego, Sara, Carrasco-Esteban, Eliseo, Sancho-García, Sonsoles, López-Campos, Fernando
Publikováno v:
In Reports of Practical Oncology & Radiotherapy March-April 2020 25(2):163-167
Autor:
Fernando López-Campos, Antonio Conde-Moreno, Marta Barrado Los Arcos, Antonio Gómez-Caamaño, Raquel García-Gómez, Asunción Hervás Morón
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 11, p 1190 (2021)
The treatment for nonmetastatic castration-resistant prostate cancer (nmCRPC) is a highly unmet medical need. The classic treatment approach for these patients—androgen deprivation therapy (ADT) alone—until metastatic progression is now considere
Externí odkaz:
https://doaj.org/article/ebbad03a6fdf4b23a5af69a2cb8f690b
Autor:
Asunción Hervás-Morón, Jose Domínguez-Rullán, Victor Duque Santana, Mireia Valero, Carmen Vallejo, Sonsoles Sancho, Juan David García Fuentes, Miguel Cámara Gallego, Fernando López-Campos
Publikováno v:
World Journal of Clinical Oncology. 13:652-662
Approximately 30% of patients with localized prostate cancer (PCa) who undergo radical prostatectomy will develop biochemical recurrence. In these patients, the only potentially curative treatment is postoperative radiotherapy (PORT) with or without
Autor:
Amalia Palacios Eito, José Pardo Masferrer, Xavier Maldonado Pijoan, Asunción Hervás Morón, Julia Luisa Muñoz García, José López Torrecilla, Antonio Gómez-Caamaño, Paloma Anguita-Alonso, Víctor Macías Hernández, Almudena Zapatero, Cristina González-Junco
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-11 (2021)
Health and Quality of Life Outcomes
Scientia
Health and Quality of Life Outcomes
Scientia
Background Health-related quality of life (HRQoL) is greatly affected by prostate cancer (PCa) and associated treatments. This study aimed to measure the impact of radiotherapy on HRQoL and to further validate the Spanish version of the 16-item Expan
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Felipe Couñago Lorenzo, Fernando López Campos, Gemma Sancho Pardo, Thomas Zilli, Asunción Hervás Morón, Xavier Maldonado Pijoan
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 39:346-350
Approximately 30% of patients who undergo radical prostatectomy for prostate cancer develop disease progression. The only potentially curative treatment in these patients is postoperative radiotherapy with or without hormonotherapy. One of the standa
Autor:
Antonio J. Conde-Moreno, Fernando López-Campos, Asunción Hervás Morón, Marta Barrado Los Arcos, Raquel García-Gómez, Antonio Gómez-Caamaño
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 1190, p 1190 (2021)
Journal of Personalized Medicine
Journal of Personalized Medicine
The treatment for nonmetastatic castration-resistant prostate cancer (nmCRPC) is a highly unmet medical need. The classic treatment approach for these patients—androgen deprivation therapy (ADT) alone—until metastatic progression is now considere
Autor:
V. Duque Santana, A. Hervás Morón, J. Domínguez Rullán, C. Vallejo Ocaña, M. Martín Martín, M. Valero Perena, R. Moris Pablos, D. Sevillano Martinez, S. Sancho García
Publikováno v:
Radiotherapy and Oncology. 170:S930-S931